Volume 62, Issue 6, Pages (December 2002)

Slides:



Advertisements
Similar presentations
Volume 78, Issue 12, Pages (December 2010)
Advertisements

Volume 65, Issue 1, Pages (January 2004)
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 83, Issue 5, Pages (May 2013)
Volume 64, Issue 6, Pages (December 2003)
Volume 80, Issue 2, Pages (July 2011)
Volume 79, Issue 9, Pages (May 2011)
Volume 55, Issue 6, Pages (June 1999)
Volume 72, Issue 10, Pages (November 2007)
Volume 81, Issue 2, Pages (January 2012)
Volume 56, Issue 4, Pages (October 1999)
Volume 78, Issue 12, Pages (December 2010)
Volume 82, Issue 1, Pages (July 2012)
Volume 67, Issue 5, Pages (May 2005)
Volume 37, Issue 6, Pages (December 2012)
Volume 82, Issue 1, Pages (July 2012)
Volume 65, Issue 1, Pages (January 2004)
Volume 75, Issue 10, Pages (May 2009)
Volume 72, Issue 7, Pages (October 2007)
Volume 80, Issue 9, Pages (November 2011)
Volume 54, Issue 4, Pages (October 1998)
Volume 63, Issue 1, Pages (January 2003)
Volume 56, Issue 6, Pages (December 1999)
Volume 83, Issue 6, Pages (June 2013)
Volume 87, Issue 5, Pages (May 2015)
Volume 70, Issue 7, Pages (October 2006)
Volume 69, Issue 1, Pages (January 2006)
Volume 59, Issue 4, Pages (April 2001)
Volume 55, Issue 4, Pages (April 1999)
Volume 56, Issue 3, Pages (September 1999)
Volume 64, Issue 4, Pages (October 2003)
A new mouse model of immune-mediated podocyte injury
Volume 58, Issue 5, Pages (November 2000)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
A human monoclonal antibody against the collagen type IV α3NC1 domain is a non- invasive optical biomarker for glomerular diseases  Kapil Chaudhary, Daniel.
Volume 72, Issue 3, Pages (August 2007)
Volume 66, Issue 3, Pages (September 2004)
Volume 70, Issue 2, Pages (July 2006)
Volume 65, Issue 1, Pages (January 2004)
Regulatory interactions of αβ and γλ T cells in glomerulonephritis
Akira Shimizu, Kazuhiko Yamada, David H. Sachs, Robert B. Colvin 
Local macrophage proliferation in human glomerulonephritis
Prevention of mesangial sclerosis by bone marrow transplantation
Volume 53, Issue 5, Pages (May 1998)
Volume 65, Issue 5, Pages (May 2004)
Volume 56, Issue 5, Pages (November 1999)
Volume 68, Issue 2, Pages (August 2005)
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H–deficient mice  Jessy J. Alexander, Lee Chaves, Anthony Chang,
Volume 71, Issue 7, Pages (April 2007)
Volume 66, Issue 4, Pages (October 2004)
Volume 81, Issue 2, Pages (January 2012)
Volume 74, Issue 6, Pages (September 2008)
Volume 60, Issue 6, Pages (December 2001)
Volume 57, Issue 2, Pages (October 2000)
Volume 89, Issue 4, Pages (April 2016)
Volume 67, Issue 3, Pages (March 2005)
Volume 85, Issue 1, Pages (January 2014)
Volume 65, Issue 6, Pages (June 2004)
Volume 66, Issue 3, Pages (September 2004)
Volume 58, Issue 1, Pages (July 2000)
Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist  Scott E. Wenderfer, Stanislaw.
Volume 62, Issue 1, Pages (July 2002)
Volume 63, Issue 1, Pages (January 2003)
Volume 58, Issue 3, Pages (September 2000)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 58, Issue 5, Pages (November 2000)
Volume 80, Issue 9, Pages (November 2011)
Unmasking a unique glomerular lesion
Volume 78, Issue 3, Pages (August 2010)
Volume 56, Issue 4, Pages (October 1999)
Presentation transcript:

Volume 62, Issue 6, Pages 2087-2096 (December 2002) Nephrotoxic nephritis is mediated by Fcγ receptors on circulating leukocytes and not intrinsic renal cells  Ruth M. Tarzi, Kevin A. Davies, Michael G. Robson, Liliane Fossati-Jimack, Takashi Saito, Mark J. Walport, H. Terence Cook  Kidney International  Volume 62, Issue 6, Pages 2087-2096 (December 2002) DOI: 10.1046/j.1523-1755.2002.00687.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Flow cytometric profiles of peripheral blood monocytes/granulocytes from wild-type (A) and FcRγ-/- (B), and bone marrow transplanted mice (C, WT donor and FcRγ-/- recipient;D, FcRγ-/- donor and WT recipient) stained for FcγRIII. FcγRII was first blocked with murine anti-Ly17.2 (anti-FcγRII), and then FITC-conjugated 2.4G2 (anti-FcγRII/III) was used to stain FcγRIII. Monocytes and granulocytes were gated by size and granularity, and B cells were excluded by B220 staining. The percentages indicate the proportion of cells staining positively as indicated by the marker. Eight weeks post-transplant, the majority of the circulating cells from the transplants were of the donor phenotype. Kidney International 2002 62, 2087-2096DOI: (10.1046/j.1523-1755.2002.00687.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Renal disease of bone marrow transplanted mice day 4 post-induction of glomerulonephritis with 10mg nephrotoxic serum IV. (A) Glomerular thrombosis score of PAS stained kidney sections. (B) Serum albumin (g/L) at day 4. (C) Glomerular mouse IgG deposition assessed by quantitative immunofluorescence (AFU, arbitrary fluorescence units); (D) glomerular C3 deposition assessed by quantitative immunofluorescence of frozen tissue sections. *P < 0.05, **P < 0.01, Kruskal-Wallis test. Kidney International 2002 62, 2087-2096DOI: (10.1046/j.1523-1755.2002.00687.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Representative histology of PAS stained kidney sections at day 8 post-induction of glomerulonephritis with 5mg nephrotoxic serum IV to bone marrow transplanted mice. (A) Wild-type (WT) marrow transplanted to WT mouse. (B) FcRγ-/- marrow transplanted to FcRγ-/- mouse. (C) WT marrow transplanted to FcRγ-/- mouse. (D) FcRγ-/- marrow transplanted to WT mouse. There was crescent formation and thrombosis of glomerular capillaries in mice transplanted with WT marrow. The kidneys of the mice transplanted with FcRγ-/- marrow were virtually normal at day 8 post-nephritis induction. Kidney International 2002 62, 2087-2096DOI: (10.1046/j.1523-1755.2002.00687.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 4 Accelerated nephrotoxic nephritis day 8 post-nephrotoxic serum injection (5 mg) in bone marrow transplanted mice and wild-type controls. (A) Albuminuria mg/24 h. (B) Percent of glomerular crescents (N = 50). (C) Quantitative immunofluorescence for deposited glomerular mouse IgG. WT mice transplanted with FcRγ-/- marrow were protected from disease. *NS, no significant difference. Kidney International 2002 62, 2087-2096DOI: (10.1046/j.1523-1755.2002.00687.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 5 Representative histology showing PAS stained glomeruli (A–C) and glomerular immunoperoxidase staining for macrophages (brown cells) counterstained with hematoxylin (D–F). A and D show glomeruli from a non-nephrotic mouse three months after bone marrow transplant. B and E depict glomeruli from an FcRγ-/- mouse transplanted with FcRγ-/- marrow day 28 after nephrotoxic serum injection (5mg IV); mesangial matrix deposition, hypercellularity and macrophage influx can be seen. C and F glomeruli are from a WT mouse transplanted with FcRγ-/- marrow, showing mesangial matrix deposition, hypercellularity and a macrophage influx at day 28 after nephrotoxic serum injection (5mg IV). Kidney International 2002 62, 2087-2096DOI: (10.1046/j.1523-1755.2002.00687.x) Copyright © 2002 International Society of Nephrology Terms and Conditions